Story · Medicine & Biotech

FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer

2 outlets · first reported by FDA Drug Safety / Drugs feed on · latest · 3 hours of coverage

FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer (FDA Drug Safety / Drugs feed)

Coverage, in order

  1. first FDA Drug Safety / Drugs feed indie
    FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer

    FDA approves durvalumab with enfortumab vedotin-ejfv for muscle invasive bladder cancer

  2. OncoDaily obscure
    FDA Approves Durvalumab Plus Enfortumab Vedotin for Muscle-Invasive Bladder Cancer

    Auf YouTube findest du die angesagtesten Videos und Tracks. Außerdem kannst du eigene Inhalte hochladen und mit Freunden oder gleich der ganzen Welt teilen.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.